Functional deficits, decreased strength, and health-related impairments after an Achilles tendon rupture (ATR) are common in patients treated both surgically and nonsurgically.^[@bibr5-2325967120906522],[@bibr8-2325967120906522],[@bibr25-2325967120906522],[@bibr33-2325967120906522],[@bibr35-2325967120906522],[@bibr36-2325967120906522],[@bibr43-2325967120906522]^ Early functional mobilization (EFM) compared with cast immobilization is reported to enhance short- and long-term outcomes after an ATR.^[@bibr11-2325967120906522],[@bibr30-2325967120906522]^ The deficits associated with an ATR and ankle immobilization may occur from excessive tendon elongation,^[@bibr24-2325967120906522],[@bibr41-2325967120906522]^ loss of calf muscle function,^[@bibr22-2325967120906522],[@bibr32-2325967120906522],[@bibr44-2325967120906522]^ or sustaining deep venous thrombosis (DVT) postoperatively.^[@bibr17-2325967120906522],[@bibr26-2325967120906522]^ DVT has been demonstrated as a predictor of suboptimal functional outcomes at 1 year after ATR repair.^[@bibr2-2325967120906522]^ It is, however, still unclear whether EFM may counteract the negative impact of ankle immobilization indirectly (eg, via the reduction of DVT) or directly via enhanced calf muscle function.

Functional mobilization protocols vary greatly, and few studies have allowed loading in combination with ankle motion immediately after surgery.^[@bibr12-2325967120906522],[@bibr28-2325967120906522],[@bibr39-2325967120906522]^ Functional mobilization, aiming to minimize long-term calf muscle atrophy and strength deficits,^[@bibr11-2325967120906522]^ should be performed early after an injury, which may be less of a concern when an ATR is surgically repaired.^[@bibr25-2325967120906522],[@bibr29-2325967120906522],[@bibr36-2325967120906522],[@bibr45-2325967120906522]^ Whether immediate postoperative weightbearing affects the degree of tendon elongation in the short and long term has, however, not been established. In addition to weightbearing, increased ankle motion may exert beneficial effects on calf muscle activation^[@bibr7-2325967120906522]^ and tendon recovery^[@bibr9-2325967120906522],[@bibr18-2325967120906522],[@bibr39-2325967120906522],[@bibr47-2325967120906522]^ as well as minimize the incidence of DVT.^[@bibr42-2325967120906522]^ Calf muscle activation compresses the veins in the calf and increases blood flow, which in turn may decrease the risk of DVT^[@bibr10-2325967120906522],[@bibr14-2325967120906522],[@bibr16-2325967120906522],[@bibr42-2325967120906522],[@bibr46-2325967120906522]^ after an ATR. Utilizing a postoperative protocol that combines immediate weightbearing and ankle movement might further improve both the short- and long-term outcomes in patients after an ATR.

Therefore, in this randomized controlled trial, patients receiving EFM were instructed to bear weight as tolerated immediately postoperatively in an ankle dynamic orthosis that also allowed partial ankle joint motion. The control group received standard treatment including 2 weeks of immobilization in a below-knee plaster cast, which was followed by weightbearing in an ankle-stable orthosis.

The primary aim of this randomized controlled trial was to assess the efficacy of postoperative EFM compared with standard treatment with regard to the outcomes of disease-specific and general health questionnaires as well as functional tests in patients with an ATR. EFM during the initial 6 weeks was compared with standard treatment, which included 2 weeks in a plaster cast followed by 4 weeks of immobilization in an ankle-stable orthosis. The secondary aim was to explore whether the occurrence of DVT during the 2 postoperative treatments affected the 6- and 12-month patient-reported and functional outcomes after ATR.

Methods {#section1-2325967120906522}
=======

Ethical approval was obtained from the regional ethical committee in Stockholm, Sweden. The study was registered on [ClinicalTrials.gov](https://ClinicalTrials.gov) (NCT02318472). All participants received oral and written information about the study procedure and provided written informed consent before surgery.

Patients {#section2-2325967120906522}
--------

Between December 2013 and February 2018, there were 311 patients with an acute ATR who were screened for eligibility at Karolinska University Hospital, Södersjukhuset, and Danderyd Hospital in Stockholm. Of these, 150 patients (114 men, 36 women) were enrolled and randomized postoperatively. Randomization was achieved using consecutively numbered sealed envelopes produced by a biostatistician and opened after surgery ([Figure 1](#fig1-2325967120906522){ref-type="fig"}). Enrollment and exclusion criteria are reported elsewhere.^[@bibr3-2325967120906522]^

![CONSORT (Consolidated Standards of Reporting Trials) flowchart. DVT, deep venous thrombosis; EFM, early functional mobilization.](10.1177_2325967120906522-fig1){#fig1-2325967120906522}

In the present study, those patients who attended the 6-month follow-up were included. A total of 135 patients, aged between 18 and 75 years, with an acute unilateral ATR surgically repaired within 1 week of injury met the criteria for this study ([Figure 1](#fig1-2325967120906522){ref-type="fig"}).

Study Procedure {#section3-2325967120906522}
---------------

All surgeons were instructed to use the same standardized surgical technique: the modified Kessler suture technique.^[@bibr17-2325967120906522]^ Directly after surgery, patients were randomized into 1 of 2 groups with a ratio of 2 (intervention) to 1 (control).^[@bibr3-2325967120906522],[@bibr47-2325967120906522]^ The intervention group received EFM in a dynamic orthosis (VACOped; OPED) with adjustable range of motion of the ankle joint. The orthosis was initially set with a range of motion of 15° to 30° of plantarflexion, and patients could bear weight as tolerated. At 2 weeks, the range of motion was increased to 5° to 30° of plantarflexion for the following 4 weeks. Full weightbearing was allowed. The patients were encouraged to perform unloaded plantarflexion exercises immediately postoperatively (from neutral and free plantarflexion) for 1 hour per day without the orthosis.

Patients in the control group received standard treatment with immobilization in a below-knee plaster cast for 2 weeks and were nonweightbearing with crutches. After removal of the cast, at 2 weeks postoperatively, the patients received a stable orthosis (Aircast AirSelect Elite; DJO) fixed at the ankle joint. Full weightbearing was allowed. The orthosis was provided with 3 heel wedges that were gradually removed during the following 4 weeks. After the 2-week follow-up visit, both groups were instructed to perform unloaded plantarflexion exercises several times per day without the orthosis.

At 6 weeks, the orthosis was discontinued in both groups, and patients were advised to wear normal shoes with a heel lift on the injured side for another month. Both groups were given the same rehabilitation protocol, and patients were advised to contact a physical therapist in primary care for supervised rehabilitation.

Evaluations at Follow-up {#section4-2325967120906522}
------------------------

### Patient-Reported Outcomes {#section6-2325967120906522}

Questionnaires were sent home to the patients before the follow-up visit and were returned at the follow-up visits at 6 and 12 months. Patients filled out 5 self-administered questionnaires at 6 and 12 months postoperatively. The Achilles tendon Total Rupture Score (ATRS)^[@bibr34-2325967120906522]^ consists of 10 items and is scored from 0 ("worst") to 10 ("best"). A total score of 100 is computed. A low score indicates more symptoms and greater limitations in physical activity after treatment of ATR. The Physical Activity Scale^[@bibr19-2325967120906522],[@bibr38-2325967120906522]^ is used to evaluate physical activity before and after an injury. It is scored from 1 (no physical activity) to 6 (heavy physical exercise several times per week). The RAND 36-Item Health Survey (RAND-36)^[@bibr20-2325967120906522],[@bibr21-2325967120906522]^ is a health-related quality of life questionnaire that consists of 36 items on physical and psychosocial health. It is divided into 8 subscales and scored on a verbal rating scale with different scoring alternatives. A higher subscale score indicates better health status. The Foot and Ankle Outcome Score (FAOS)^[@bibr37-2325967120906522]^ consists of 42 items evaluating foot- and ankle-related symptoms, pain, function in activities of daily living (ADL) and in sports and recreation (Sports/Rec), and quality of life in relation to foot problems (QoL). The questionnaire is divided into 5 subscales, and the score ranges from 0 (worst) to 100 (best). The Tampa Scale of Kinesiophobia, Swedish version,^[@bibr27-2325967120906522]^ comprises 17 items and is scored on a 4-point Likert scale with alternatives ranging from 1 (strongly disagree) to 4 (strongly agree). A total sum of the 17 items is calculated, with scores ranging from 17 to 68. A high score (\>37) is defined as kinesiophobia.^[@bibr27-2325967120906522]^

### Functional Outcomes {#section7-2325967120906522}

Functional evaluations were performed at the follow-up visits at 6 and 12 months at the physical therapy department. All tests were performed by 1 physical therapist (S.A.) not involved in the patients' rehabilitation but not blinded to treatment regimens.

A calf muscle endurance heel-rise test was performed as described earlier.^[@bibr40-2325967120906522]^ The Musclelab linear encoder (Ergotest) was used for data collection. The tests were performed in the same order, and the uninjured side was tested first. Standardized footwear was used. Patients warmed up on a stationary bike for 5 minutes, followed by 10 repetitions of 2-leg heel rises before testing. During the heel-rise test, verbal encouragement was given. The patient was instructed to go as high as possible on each heel rise with a straight knee. A metronome was used for a standardized frequency of 30 heel rises per minute. The test was terminated when the patient stopped or could not maintain frequency.

At the 12-month follow-up, 2 different jump tests were added. The first test was the vertical jump test as a measure of explosive strength in the lower extremity.^[@bibr15-2325967120906522]^ Patients rated their perceived fear, pain, and discomfort when jumping from 0 to 10 on a visual analog scale. The other test was the side hop test in which the patient performed 10 jumps sideways on 1 leg for time.^[@bibr23-2325967120906522]^ The uninjured leg was tested first. For the vertical jump test, the best of 3 attempts was counted, and for the side hop test, only 1 trial was performed. The jump tests were performed after the heel-rise test.

For the functional assessments, 120 patients were evaluated at the 6-month follow-up, at a mean time of 6.4 ± 0.7 months after surgery, and 123 patients were evaluated at the 12-month follow-up, at a mean time of 12.4 ± 0.5 months after surgery.

### Assessment of DVT {#section8-2325967120906522}

All patients were screened for DVT in the injured leg using unilateral compression duplex ultrasound at 2 and 6 weeks postoperatively.^[@bibr3-2325967120906522]^ A trained nurse or an experienced ultrasonographer, blinded to the treatment regimens, performed all the compression duplex ultrasound scans using a CX50 ultrasound machine (Philips).^[@bibr3-2325967120906522]^

Statistical Analysis {#section10-2325967120906522}
====================

This study was initially powered for the risk of DVT with EFM, and inclusion was performed with a 2:1 ratio.^[@bibr3-2325967120906522]^ All descriptive statistics as well as the analyses were conducted in SPSS (Version 25.0; IBM). Descriptive data were reported as the mean, standard deviation, and frequency. The continuous variables (heel-rise test) were scrutinized for severely skewed distributions or outliers. However, no skewness was found, and thus, differences between the groups in these variables were analyzed with the parametric Student *t* test. The nonparametric Mann-Whitney *U* test was used to compare differences between the groups in the outcome questionnaires. A paired Student *t* test was used for comparisons of the heel-rise variables between the 6- and 12-month follow-up visits and the Wilcoxon signed-rank test for comparing paired ordinal data. Comparisons for categorical variables between the groups were performed with the Pearson chi-square test. A 2-way analysis of variance was conducted to examine whether there was an effect of treatment and the occurrence of DVT on variables from the heel-rise test and ATRS. The limb symmetry index (LSI) was used to compare the groups on the heel-rise test. The LSI was defined as the ratio between the injured and uninjured limbs, expressed as a percentage (LSI = injured/uninjured × 100). The level of significance was *P* ≤ .05 for all analyses.

Results {#section11-2325967120906522}
=======

Most injuries were sports related, and the most common causes of injury were football (26%; 35/135) and badminton (16%; 22/135), while 7 injuries (5%) were not sports related. Moreover, demographic and clinical characteristics are presented in [Table 1](#table1-2325967120906522){ref-type="table"}. There were no significant differences in patient characteristics between the groups (all *P* \> .05).

###### 

Demographic and Clinical Characteristics of Participants*^a^*

![](10.1177_2325967120906522-table1)

                             EFM (n = 89)   Control (n = 46)
  -------------------------- -------------- ------------------
  Age, y                     39.4 ± 8.1     39.7 ± 8.0
  Male sex, n (%)            67 (75)        35 (76)
  Body mass index, kg/m^2^   24.9 ± 2.6     25.0 ± 2.5
  Nicotine use, n (%)        19 (21)        6 (13)
  Left side injured, n (%)   46 (52)        25 (54)
  Time to surgery, d         3.7 ± 1.7      3.6 ± 1.6
  Infection, n (%)           1 (1)          1 (2)
  DVT, n (%)                 34 (39)        14 (30)
  PAS score before injury    4.7 ± 1.0      4.6 ± 1.0

*^a^*Values are reported as mean ± SD unless otherwise specified. DVT, deep venous thrombosis; EFM, early functional mobilization; PAS, Physical Activity Scale.

Outcomes by Treatment Group {#section12-2325967120906522}
---------------------------

### Patient-Reported Outcomes {#section14-2325967120906522}

At 6 months, the mean ATRS value was 65.1 ± 19.2 in the EFM group and 59.1 ± 21.4 in the control group (*P* = .134). Also at 6 months, the EFM group scored significantly higher on the RAND-36 subscales of general health (*P* = .012) and vitality (*P* = .022) compared with the control group. Moreover, the EFM group exhibited higher values on the RAND-36 subscale of role functioning/physical at 6 months, but the data were not statistically significant (*P* = .051) ([Table 2](#table2-2325967120906522){ref-type="table"}). No other significant differences in patient-reported outcomes were seen at 6 months.

Significant improvements (all *P* \< .05) from 6 to 12 months were observed in self-reported function, pain, and QoL in both groups ([Table 2](#table2-2325967120906522){ref-type="table"}). At 12 months, no significant differences in any of the patient-reported outcomes were seen between the groups. The RAND-36 subscale of general health, however, exhibited higher values in the EFM group (82.6 ± 16.9) than the control group (77.1 ± 17.0) (*P* = .051) at 12 months after injury.

###### 

Patient-Reported Outcomes by Treatment Group*^a^*

![](10.1177_2325967120906522-table2)

                    6 mo                   12 mo                  *P* Value*^b^*                                                                     
  ----------------- ---------------------- ---------------------- ---------------- ---------------------- ---------------------- ------ ------------ ------------
  ATRS              65.1 ± 19.2 (n = 77)   59.1 ± 21.4 (n = 40)   .134             80.3 ± 15.9 (n = 76)   81.1 ± 15.7 (n = 41)   .846   **\<.001**   **\<.001**
  PAS               4.0 ± 1.1 (n = 73)     3.9 ± 1.1 (n = 40)     .618             4.2 ± 1.1 (n = 75)     4.3 ± 1.1 (n = 40)     .598   .195         **.036**
  FAOS pain         88.3 ± 11.8 (n = 77)   86.6 ± 12.7 (n = 40)   .498             93.2 ± 9.5 (n = 76)    94.5 ± 8.1 (n = 41)    .594   **\<.001**   **.002**
  FAOS symptoms     81.2 ± 15.1            77.3 ± 17.1            .245             87.3 ± 13.1            85.1 ± 15.8            .576   **.003**     **.009**
  FAOS ADL          93.8 ± 8.8             93.0 ± 6.9             .191             96.7 ± 6.4             97.1 ± 5.5             .840   **\<.001**   **\<.001**
  FAOS Sports/Rec   69.9 ± 20.9            64.9 ± 19.4            .104             81.8 ± 16.3            81.6 ± 15.3            .777   **\<.001**   **\<.001**
  FAOS QoL          60.3 ± 17.1            56.6 ± 17.7            .294             72.8 ± 18.3            72.6 ± 15.8            .776   **\<.001**   **\<.001**
  RAND-36 PF        84.0 ± 13.3 (n = 77)   83.0 ± 12.4 (n = 40)   .440             90.4 ± 12.5 (n = 75)   90.6 ± 11.2 (n = 41)   .816   **\<.001**   **.001**
  RAND-36 RP        78.6 ± 33.4            65.6 ± 37.0            .051             88.3 ± 26.7            89.6 ± 25.0            .639   .073         **.001**
  RAND-36 BP        84.6 ± 16.4 (n = 76)   82.9 ± 17.5 (n = 39)   .642             90.4 ± 16.6            92.5 ± 9.0             .865   **.012**     **.003**
  RAND-36 GH        83.2 ± 14.1            74.8 ± 18.2            **.012**         82.6 ± 16.9            77.1 ± 17.0            .051   .485         .568
  RAND-36 VT        70.4 ± 18.5            61.0 ± 20.4            **.022**         69.0 ± 20.4            64.9 ± 20.2            .258   .275         .357
  RAND-36 SF        88.9 ± 15.8            84.2 ± 19.1            .125             91.8 ± 16.9            88.5 ± 20.3            .569   .090         .480
  RAND-36 RE        83.1 ± 33.2            88.4 ± 27.8            .577             93.8 ± 20.3            87.0 ± 30.7            .282   **.030**     .388
  RAND-36 MH        82.9 ± 11.9            80.3 ± 15.5            .721             82.5 ± 13.5            81.0 ± 15.3            .785   .714         .921
  TSK-SV            31.8 ± 7.3 (n = 68)    30.8 ± 6.2 (n = 38)    .792             28.9 ± 7.4 (n = 73)    30.3 ± 7.0 (n = 37)    .258   **.002**     .268

*^a^*Values are reported as mean ± SD. Bolded values indicate statistical significance (*P* \< .05). ADL, activities of daily living; ATRS, Achilles tendon Total Rupture Score; BP, bodily pain; EFM, early functional mobilization; FAOS, Foot and Ankle Outcome Score; GH, general health; MH, mental health; PAS, Physical Activity Scale; PF, physical functioning; QoL, quality of life; RAND-36, RAND 36-Item Health Survey; RE, role functioning/emotional; RP, role functioning/physical; SF, social functioning; Sports/rec, sports and recreation; TSK-SV, Tampa Scale of Kinesiophobia, Swedish version; VT, vitality.

*^b^*Change from 6 to 12 months with the Wilcoxon signed-rank test for comparison of paired observations.

### Functional Outcomes {#section15-2325967120906522}

There were no significant differences (all *P* \> .05) between the EFM and control groups on the heel-rise test at neither 6 or 12 months postoperatively or on the jump tests ([Table 3](#table3-2325967120906522){ref-type="table"}). The injured side was significantly improved (*P* \< .01) between the 6- and 12-month follow-up visits for all variables in the heel-rise test but was still significantly worse than the healthy side ([Appendix Table A1](#table5-2325967120906522){ref-type="table"}).

4-Group Analysis {#section17-2325967120906522}
================

Because the incidence of DVT in both treatment groups was high postoperatively,^[@bibr3-2325967120906522]^ a secondary analysis with a 4-group (treatment group × DVT) design was performed to evaluate the effect of treatment group and DVT on outcomes. There were no significant interaction effects of group (EFM vs control) and DVT for any of the patient-reported or functional outcomes at 6 or 12 months (*P* \> .05).

###### 

Functional Outcomes by Treatment Group*^a^*

![](10.1177_2325967120906522-table3)

                                    6 mo                             12 mo                                                                                                   
  --------------------------------- -------------------------------- ------------------------------- ------ ------------------------------- -------------------------------- ------
  Total concentric work, J                                                                                                                                                   
   Injured side                     1382.4 ± 654.4 (0.0-3760.9)      1531.1 ± 651.6 (45.1-2630.8)           1776.1 ± 677.8 (176.2-3602.6)   2077.8 ± 744.4 (272.6-4373.2)    
   Uninjured side                   2367.7 ± 647.6 (1120.9-3966.3)   2596.7 ± 817.5 (880.4-4376.5)          2446.1 ± 728.6 (916.0-4338.8)   2675.6 ± 798.9 (1094.0-4895.7)   
   LSI, %                           58.6 ± 23.0 (0.0-104.3)          58.6 ± 21.2 (5.1-100.1)         .999   74.4 ± 23.0 (7.0-121.6)         77.7 ± 19.5 (24.9-119.6)         .433
  No. of heel rises                                                                                                                                                          
   Injured side                     22.0 ± 8.3 (0-54)                23.4 ± 8.6 (3-57)                      25.7 ± 8.1 (4-50)               27.7 ± 9.3 (12-59)               
   Uninjured side                   27.6 ± 6.9 (14-46)               29.2 ± 8.8 (15-59)                     28.0 ± 7.2 (15-49)              29.3 ± 8.8 (16-60)               
   LSI, %                           80.3 ± 22.1 (0.0-140.9)          80.0 ± 21.5 (16.7-122.7)        .954   92.6 ± 20.5 (13.3-135.1)        95.3 ± 20.7 (63.3-172.7)         .508
  Maximum height of heel rise, cm                                                                                                                                            
   Injured side                     9.9 ± 2.5 (0.0-15.3)             10.0 ± 2.9 (2.3-14.7)                  11.0 ± 2.4 (5.9-15.6)           11.9 ± 2.3 (4.1-16.3)            
   Uninjured side                   13.7 ± 1.8 (10.1-17.5)           13.7 ± 2.1 (9.1-17.5)                  14.0 ± 2.0 (9.2-19.6)           14.3 ± 1.9 (11.0-18.7)           
   LSI, %                           72.3 ± 18.1 (0.0-123.3)          73.3 ± 19.5 (23.0-107.4)        .776   79.2 ± 15.9 (36.9-127.9)        83.4 ± 12.8 (33.6-108.4)         .151
  Vertical jump test, cm                                                                                                                                                     
   Injured side                                                                                             24.3 ± 6.5                      23.6 ± 6.4                       
   Uninjured side                                                                                           27.5 ± 6.9                      27.3 ± 6.2                       
   LSI, %                                                                                                   89.2 ± 14.6                     86.9 ± 15.1                      .431
  Side hop test, s                                                                                                                                                           
   Injured side                                                                                             4.7 ± 1.5                       4.9 ± 1.6                        
   Uninjured side                                                                                           4.7 ± 1.5                       4.7 ± 1.7                        
   LSI, %                                                                                                   100.3 ± 12.3                    103.1 ± 13.4                     .260

*^a^*Values are reported as mean ± SD or mean ± SD (range). EFM, early functional mobilization; LSI, limb symmetry index (injured/uninjured × 100).

Outcomes by DVT {#section18-2325967120906522}
===============

 {#section19-2325967120906522}

### Patient-Reported Outcomes {#section20-2325967120906522}

Patients who experienced DVT exhibited significantly lower self-reported outcomes on the ATRS, FAOS subscales of ADL and QoL, and RAND-36 subscales of physical functioning and role functioning/emotional at 6 months compared with patients not having sustained DVT (all *P* \< .05) ([Table 4](#table4-2325967120906522){ref-type="table"}).

Patients who had sustained DVT demonstrated significantly worse outcomes on the ATRS; FAOS subscales of ADL, Sports/Rec, and QoL; and RAND-36 subscales of physical functioning, general health, vitality, and mental health at 12 months than patients without DVT (all *P* \< .05). At 12 months, patients who had sustained DVT also presented with a higher degree of kinesiophobia than patients without diagnosed DVT (*P* = .013) ([Table 4](#table4-2325967120906522){ref-type="table"}).

###### 

Patient-Reported and Functional Outcomes by Presence of DVT*^a^*

![](10.1177_2325967120906522-table4)

                    6 mo                   12 mo                  *P* Value*^b^*                                                                         
  ----------------- ---------------------- ---------------------- ---------------- ---------------------- ---------------------- ---------- ------------ ------------
  ATRS              66.2 ± 19.8 (n = 72)   57.4 ± 19.4 (n = 44)   **.022**         83.4 ± 15.4 (n = 72)   75.8 ± 15.8 (n = 44)   **.003**   **\<.001**   **\<.001**
  PAS               4.0 ± 1.1 (n = 71)     3.9 ± 1.2 (n = 41)     .587             4.3 ± 1.1 (n = 71)     4.1 ± 1.2 (n = 43)     .468       **.031**     .374
  FAOS pain         88.1 ± 12.4 (n = 73)   86.9 ± 11.6 (n = 44)   .520             94.3 ± 8.6 (n = 72)    92.3 ± 9.6 (n = 44)    .226       **\<.001**   **.010**
  FAOS symptoms     80.9 ± 15.3            78.1 ± 16.8            .384             87.2 ± 13.1            85.2 ± 15.8            .546       **.004**     **.009**
  FAOS ADL          94.1 ± 8.4             92.3 ± 7.8             **.046**         97.6 ± 5.7             95.6 ± 6.5             **.006**   **\<.001**   **\<.001**
  FAOS Sports/Rec   70.9 ± 20.3            63.4 ± 20.3            .087             84.4 ± 14.3            77.2 ± 17.6            **.035**   **\<.001**   **\<.001**
  FAOS QoL          61.6 ± 18.4            54.5 ± 14.8            **.024**         76.2 ± 16.5            66.8 ± 17.6            **.009**   **\<.001**   **.001**
  RAND-36 PF        85.8 ± 12.1 (n = 72)   80.0 ± 13.6 (n = 44)   **.011**         92.2 ± 10.9 (n = 71)   87.5 ± 13.3 (n = 44)   **.007**   **\<.001**   **\<.001**
  RAND-36 RP        77.1 ± 35.0            68.8 ± 35.0            .116             90.5 ± 24.8            85.8 ± 28.2            .288       **.027**     **.003**
  RAND-36 BP        84.3 ± 17.2 (n = 71)   83.1 ± 16.2 (n = 43)   .582             92.0 ± 12.6            89.7 ± 17.0            .587       **.007**     **.017**
  RAND-36 GH        80.5 ± 16.5            79.7 ± 15.2            .540             83.8 ± 15.7            75.1 ± 17.9            **.003**   .192         .110
  RAND-36 VT        69.6 ± 18.7            62.7 ± 20.3            .100             71.1 ± 18.1            61.5 ± 22.6            **.020**   .827         .837
  RAND-36 SF        89.2 ± 15.9            83.9 ± 18.7            .114             90.8 ± 18.8            90.2 ± 17.5            .769       .350         .080
  RAND-36 RE        89.8 ± 25.4            76.5 ± 38.5            **.042**         93.9 ± 20.6            87.1 ± 29.9            .184       .620         .060
  RAND-36 MH        83.2 ± 13.5            80.0 ± 12.8            .124             84.3 ± 13.5            78.1 ± 14.6            **.016**   .609         .795
  TSK-SV            30.6 ± 6.5 (n = 67)    33.3 ± 7.3 (n = 38)    .082             28.3 ± 7.9 (n = 68)    31.2 ± 5.8 (n = 41)    **.013**   **.007**     .070

*^a^*Values are reported as mean ± SD. Bolded values indicate statistical significance (*P* \< .05). ADL, activities of daily living; ATRS, Achilles tendon Total Rupture Score; BP, bodily pain; DVT, deep venous thrombosis; FAOS, Foot and Ankle Outcome Score; GH, general health; MH, mental health; PAS, Physical Activity Scale; PF, physical functioning; QoL, quality of life; RAND-36, RAND 36-Item Health Survey; RE, role functioning/emotional; RP, role functioning/physical; SF, social functioning; Sports/Rec, sports and recreation; TSK-SV, Tampa Scale of Kinesiophobia, Swedish version; VT, vitality.

*^b^*Change from 6 to 12 months with the Wilcoxon signed-rank test for comparison of paired observations.

### Functional Outcomes {#section21-2325967120906522}

There were no significant differences (*P* \> .05) in functional outcomes (heel-rise and jump tests) between patients with and without DVT ([Appendix Table A2](#table6-2325967120906522){ref-type="table"}).

Discussion {#section22-2325967120906522}
==========

The main finding of this study was that immediate postoperative EFM in patients with ATR resulted in significantly higher scores on general health and vitality at 6 months compared with the control group. EFM did not seem to negatively affect heel-rise function, which indicates that muscle-tendon recovery might not be greatly influenced by differences in treatment protocols.

The observed difference in health-related QoL was linked to differences in mobilization regimens between groups, independent of the occurrence of DVT. Patients suffering DVT during treatment, however, exhibited greater impairments in general health and disease-specific subjective outcomes at 6 and 12 months, independent of the postoperative treatment regimen.

An essential finding of this study was the observation that the EFM group exhibited superior health-related QoL at 6 months, as measured with the RAND-36. Suchak et al^[@bibr43-2325967120906522]^ reported that earlier weightbearing resulted in greater health-related QoL at 6 weeks; however, at the 6-month follow-up, this difference no longer existed. In this earlier study, all patients were nonweightbearing for the first 2 weeks and then randomized to weightbearing or not.^[@bibr43-2325967120906522]^ In our study, however, patients in the EFM group were allowed weightbearing from day 1 postoperatively, which may explain the differences in outcomes at 6 months between the 2 studies. Additionally, a study on nonoperatively treated patients with an ATR reported better health-related QoL in patients allowed to bear weight compared with the nonweightbearing group during treatment.^[@bibr5-2325967120906522]^

The observed difference at 6 months between the EFM and control groups on the RAND-36 subscales of general health and vitality is suggested to depend mainly on the first 2 postoperative weeks in which patients in the EFM group were weightbearing while the controls were nonweightbearing. These findings seem to reflect that direct weightbearing after an injury has essential effects on patients' more global health conditions. A possible explanation might be that patients have a faster trajectory to recovery with early loading; however, the difference evens out in the long term. The effects of weightbearing on general health and vitality may additionally depend on other factors such as the fear of loading and the number of daily steps taken. Our finding at 6 months of no difference in kinesiophobia between the 2 groups suggests that fear of loading did not affect the difference in outcomes. The number of daily steps taken has been shown to be critical for overall health^[@bibr1-2325967120906522]^ and is known to be positively correlated with increased loading.^[@bibr4-2325967120906522]^ Thus, further studies need to assess whether it is the actual amount of loading or the number of steps taken that relates to improved health and vitality.

The difference in subjective outcomes at 6 months may also be related to the varying degree of ankle motion performed in the 2 groups. The EFM group was allowed partial ankle motion within the orthosis from day 1, which was continued for 6 weeks. The control group, however, received a plaster cast for 2 weeks, followed by 4 weeks of immobilization in an ankle-stable orthosis. Movements of the ankle have been speculated to activate the calf muscle^[@bibr7-2325967120906522]^ and enhance tendon healing.^[@bibr9-2325967120906522],[@bibr18-2325967120906522],[@bibr39-2325967120906522],[@bibr47-2325967120906522]^ The observation, however, of nonsignificant differences at 6 months on the heel-rise test between the EFM and control groups suggests that the ankle motion produced within the EFM group was too small to further improve calf muscle recovery.

Despite the significant differences in RAND-36 scores at 6 months, no major differences between groups were noted in ATRS or functional outcomes. This observation seems to suggest that EFM produces an improvement in the medium term (6 months) limited to general health status, which is not paralleled by better functional enhancements. Presumably, the minor dissimilarities between the 2 rehabilitation protocols, which mainly occurred during the first 2 weeks when patients were in pain within the inflammatory healing phase, are not enough to affect tendon-muscle recovery.

Tendon elongation, which would be a severe adverse event of using aggressive EFM, has also been found to negatively affect functional outcomes.^[@bibr6-2325967120906522],[@bibr41-2325967120906522]^ Thus, the observation demonstrating no differences in the functional outcome of the LSI heel-rise height between the 2 groups suggests that tendon elongation does not seem to increase because of EFM. This conclusion is substantiated by earlier studies showing that the heel-rise height correlates with Achilles tendon length at 1 year after an ATR^[@bibr41-2325967120906522]^ and that EFM does not seem to include a risk of greater tendon elongation.^[@bibr30-2325967120906522]^

The results at 12 months showing no significant differences in functional outcomes between patients in the EFM and control groups can probably be attributed to the minor differences between the treatment groups in terms of weightbearing status. In this study, all patients from both groups were allowed weightbearing from the third week postoperative. Weightbearing from week 3 in the control group was chosen as the standard of care, which is used in many hospitals. Earlier studies comparing functional mobilization with immobilization most often used 4 to 6 weeks of nonweightbearing for the control group.^[@bibr12-2325967120906522],[@bibr13-2325967120906522],[@bibr31-2325967120906522],[@bibr43-2325967120906522]^

In this study, a further aim was to assess whether the high occurrence of DVT during leg immobilization could affect the outcomes between the 2 treatment groups. The observation that patients who experienced DVT demonstrated significantly lower self-reported outcomes on all questionnaires at 6 months was, however, not related to the postoperative treatment.

This finding suggests that the improved subjective outcomes seen in the EFM group were not affected by a reduction of DVT but rather by more direct factors such as differences in weightbearing and ankle movement between the rehabilitation protocols.

The observation that patients who had sustained DVT postoperatively reported inferior subjective outcomes also at 12 months on the ATRS, FAOS (ADL, Sports/Rec, and QoL), and RAND-36 (physical functioning, general health, vitality, and mental health) demonstrates that DVT is a major predictor for negative outcomes of an ATR. This finding is in agreement with another study^[@bibr2-2325967120906522]^ and furthermore highlights that DVT is an independent factor to address to improve long-term outcomes.

The strength of this study is that the EFM protocol used has been assessed in detail when it comes to weightbearing and the number of daily steps taken during the first 2 postoperative weeks.^[@bibr4-2325967120906522]^

The potential limitations of this study are that there were several orthopaedic surgeons involved in the surgical treatment of the patients and that the physical therapist performing the outcome tests was not blinded to the treatment regimen. Another limitation of the study was that the rehabilitation protocol was not standardized after week 6. These limitations may explain some of the variation in patient outcomes but may also make the results more generalizable in clinical practice.

Conclusion {#section23-2325967120906522}
==========

This study demonstrated that an accelerated postoperative protocol with immediate loading and ankle motion resulted in better general health and vitality at 6 months. However, there were no differences between the groups in the recovery of heel-rise function. Future studies should place an additional focus on the means to reduce the risk of DVT to improve patient outcomes after ATR.
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###### 

Side-to-Side Comparison at 6- and 12-Month Follow-up*^a^*

![](10.1177_2325967120906522-table5)

                                     6 mo   12 mo                          *P* Value*^b^*                                                                                                                   
  --------------------------------- ------- ------------------------------ -------------------------------- ------------ ---- ------------------------------- -------------------------------- ------------ ------------
  Total concentric work, J                                                                                                                                                                                  
   EFM group                        78      1382.4 ± 654.4 (0.0-3760.9)    2367.7 ± 647.6 (1120.9-3966.3)   **\<.001**   83   1776.1 ± 677.8 (176.2-3602.6)   2446.1 ± 728.6 (916.0-4338.8)    **\<.001**   **\<.001**
   Control group                    42      1531.1 ± 651.6 (45.1-2630.8)   2596.7 ± 817.5 (880.4-4376.5)    **\<.001**   40   2077.8 ± 744.4 (272.6-4373.2)   2675.6 ± 798.9 (1094.0-4895.7)   **\<.001**   **\<.001**
  No. of heel rises                                                                                                                                                                                         
   EFM group                        78      22.0 ± 8.3 (0-54)              27.6 ± 6.9 (14-46)               **\<.001**   83   25.7 ± 8.1 (4-50)               28.0 ± 7.2 (15-49)               **.001**     **\<.001**
   Control group                    42      23.4 ± 8.6 (3-57)              29.2 ± 8.8 (15-59)               **\<.001**   40   27.7 ± 9.3 (12-59)              29.3 ± 8.8 (16-60)               .078         **\<.001**
  Maximum height of heel rise, cm                                                                                                                                                                           
   EFM group                        78      9.9 ± 2.5 (0.0-15.3)           13.7 ± 1.8 (10.1-17.5)           **\<.001**   83   11.0 ± 2.4 (5.9-15.6)           14.0 ± 2.0 (9.2-19.6)            **\<.001**   **\<.001**
   Control group                    42      10.0 ± 2.9 (2.3-14.7)          13.7 ± 2.1 (9.1-17.5)            **\<.001**   40   11.9 ± 2.3 (4.1-16.3)           14.3 ± 1.9 (11.0-18.7)           **\<.001**   **\<.001**

*^a^*Values are reported as mean ± SD (range). Bolded values indicate statistical significance (*P* \< .05). EFM, early functional mobilization.

*^b^*Comparison of the injured side between the 6- and 12-month follow-up.

###### 

Heel-Rise Test Results by Presence of DVT^*a*^

![](10.1177_2325967120906522-table6)

                                    6 mo                            12 mo                                                                                                    
  --------------------------------- ------------------------------- -------------------------------- ------ ------------------------------- -------------------------------- ------
  Total concentric work, J                                                                                                                                                   
   Injured side                     1443.0 ± 655.9 (45.1-3760.9)    1438.7 ± 654.6 (0.0-2819.9)             1877.1 ± 655.3 (272.6-3347.1)   1893.0 ± 800.2 (176.2-4373.2)    
   Uninjured side                   2430.0 ± 734.6 (880.4-4161.3)   2477.4 ± 699.0 (1271.1-4376.5)          2481.1 ± 724.9 (916.0-4338.8)   2586.5 ± 821.6 (1301.5-4895.7)   
   LSI, %                           59.2 ± 21.7 (5.1-104.3)         58.5 ± 23.1 (0.0-101.2)          .873   76.9 ± 21.5 (24.9-119.6)        73.9 ± 22.0 (7.0-121.6)          .468
  No. of heel rises                                                                                                                                                          
   Injured side                     22.6 ± 8.7 (3-57)               22.4 ± 8.0 (0-46)                       26.4 ± 8.5 (12-59)              26.2 ± 8.7 (4-50)                
   Uninjured side                   28.4 ± 8.0 (14-59)              27.7 ± 7.0 (16-45)                      28.4 ± 8.1 (15-60)              28.6 ± 7.4 (17-46)               
   LSI, %                           79.2 ± 19.9 (15.6-117.6)        82.0 ± 25.3 (0.0-140.9)          .516   94.0 ± 19.8 (49.0-172.7)        92.6 ± 22.2 (13.3-135.1)         .713
  Maximum height of heel rise, cm                                                                                                                                            
   Injured side                     10.1 ± 2.6 (2.3-15.3)           9.8 ± 2.7 (0.0-14.2)                    11.5 ± 2.4 (4.1-16.3)           11.2 ± 2.3 (5.9-15.6)            
   Uninjured side                   13.6 ± 1.9 (9.1-17.2)           13.9 ± 1.9 (9.6-17.5)                   14.0 ± 2.0 (9.2-19.4)           14.1 ± 1.8 (10.4-19.6)           
   LSI, %                           74.0 ± 17.5 (23.0-123.3)        71.0 ± 19.8 (0.0-105.2)          .391   81.7 ± 13.9 (33.6-114.4)        79.6 ± 15.8 (42.9-127.9)         .458

*^a^*Values are reported as mean ± SD (range). DVT, deep venous thrombosis; LSI, limb symmetry index (injured/uninjured × 100).
